Novartis
The radiopharmaceutical, already approved for SSRT-expressing GEP-NETs, may be a new option in meningioma if future research validates findings from this small study.
UK Parkinson’s Single-Cell Research Project Kicks off With £4M From Gatsby Charitable Foundation
The three-year public-private research partnership has also garnered financial support from pharmaceutical companies GSK, Novartis, Roche, and UCB.
Family Heart Foundation Implementing Machine-Learning Tool for Identifying Patients With High Lp(a)
A group of hospital systems are using the machine-learning model to guide decisions on who should be tested for high levels of lipoprotein(a).
FDA Approves Novartis' Kisqali as Adjuvant Treatment for Early-Stage HER2-Negative Breast Cancer
The drug is approved in combination with an aromatase inhibitor as adjuvant therapy for breast cancer patients at high risk of recurrence.
Sanofi Inks €100M Radiopharmaceutical Deal With RadioMedix, Orano Med
Sanofi will gain exclusive rights to commercialize the lead-212-based radiopharmaceutical AlphaMedix in somatostatin-expressing neuroendocrine cancers.
Jul 23, 2024
Jul 18, 2024
May 21, 2024
Apr 4, 2024
Mar 19, 2024